Pfizer
PulseAugur coverage of Pfizer — every cluster mentioning Pfizer across labs, papers, and developer communities, ranked by signal.
6 day(s) with sentiment data
-
CFOs show paradox of promise vs. pessimism amid economic downturn
A recent Deloitte survey reveals a divergence in sentiment among North American CFOs, with a majority expressing optimism about their own companies' financial futures despite a worsening economic outlook. This confidenc…
-
Nike names new CFO; US pressures Meta on AI model review
Nike has appointed David M. Denton as its new Chief Financial Officer, effective August 17th. Denton, who previously served as CFO for Pfizer, brings over 30 years of financial leadership experience. He will succeed Mat…
-
Pfizer transforms manufacturing with AI-centric MES, MIT Sloan reports
MIT Sloan has detailed Pfizer's successful transition to an AI-centric Manufacturing Execution System (MES). The company shifted its approach from top-down implementation to bottom-up enablement, fostering greater trust…
-
Temasek reshapes leadership with CFO Png Chin Yee moving to new role
Temasek, Singapore's state-owned investment firm, is undergoing a significant leadership restructuring. CFO Png Chin Yee will transition to a newly created role as president of Temasek Singapore, overseeing key local po…
-
SpaceX eyes healthcare with Starlink, orbital drug manufacturing, and AI
SpaceX is exploring multiple avenues into the healthcare sector, leveraging its Starlink satellite internet service to improve remote healthcare access in underserved regions. The company also plans to manufacture pharm…
-
Chinese biotech firms eyed for US/EU market entry via outlicensing
Analysts predict that several Chinese biotechnology firms may successfully market their own branded medications in Europe and the US within the next decade. This projection is fueled by a rise in outlicensing agreements…
-
AI drug discovery firm Chai lands deals with Pfizer and Eli Lilly
Chai Discovery, an AI drug discovery startup, has secured significant partnerships with pharmaceutical giants Eli Lilly and Pfizer. The company's advanced antibody design models, including the recently deployed Chai-3, …
-
Innovent Biologics partners with Pfizer in US$10.5B cancer drug deal
Innovent Biologics has entered into a significant collaboration with Pfizer, valued at up to US$10.5 billion, to advance 12 cancer drug programs. The deal includes an upfront payment of US$650 million to Innovent, with …
-
FDA approves Pfizer and Arvinas' new breast cancer drug VEPPANU
The World Trade Organization (WTO) is planning a 10% budget cut due to member states, including the United States, failing to pay their dues. This financial strain may lead to hiring freezes and the reduction of short-t…
-
New framework enhances AI explainability for spectral data analysis
Researchers have developed the Spectral Model eXplainer (SMX), a new framework designed to improve the explainability of machine learning models used in chemometrics and spectroscopy. Unlike existing methods that focus …